Study of Eye Movement Desensitization and Reprocessing (EMDR) Working Mechanism

September 24, 2010 updated by: Technical University of Munich

Randomized Controlled Study of Eye Movement Desensitization and Reprocessing (EMDR) Working Mechanism

EMDR (Eye Movement Desensitization and Reprocessing) is an exposure-based procedure for the treatment of patients with post-traumatic stress disorder (PTSD). Although the efficiency of EMDR-treatment is empirically proven, it remains unclear whether the bilateral stimulation triggered via eye movements has specific effects on treatment outcome. Hypothesis explaining the efficacy of the EMDR treatment are: focussing on the moving hand triggers an orientation reaction, and the duality of alertness focus during trauma exposition causes a distraction of the traumatic topic.

Within a randomized controlled study 120 patients will be treated during 8 therapeutical sessions with EMDR with bilateral stimulation or one of two control conditions: EMDR without bilateral stimulation (eyes on a fixed, unmoving hand) and exposition without any visual stimuli to focus attention on. Primary outcome are scores on an interview measure for PTSD symptoms (Clinician Administered PTSD Scale (CAPS))as assessed pre-treatment and after treatment (max 8 sessions of psychotherapy).

The following hypothesis are investigated in the study:

  1. EMDR treatment with bilateral stimulation through eye movements will be followed significant larger reduction in CAPS compared with EMDR treatment without bilateral stimulation (specific treatment effect of eye movements)
  2. EMDR with eyes fixed will be followed by a significant larger reduction in CAPS compared with EMDR without external focus (specific treatment effect of distraction)

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

192

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Martin Sack, MD
  • Phone Number: +498941404312
  • Email: m.sack@tum.de

Study Contact Backup

Study Locations

      • Munich, Germany, 81675
        • Recruiting
        • Technische Universität München
        • Contact:
          • Martin Sack, MD
          • Phone Number: +498941404312
          • Email: m.sack@tum.de
        • Contact:
        • Principal Investigator:
          • Martin Sack, MD
        • Sub-Investigator:
          • Julia Körner, PHD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • the participant is able to reduce stress symptoms
  • no actual contact to offender

Exclusion Criteria:

  • drug or alcohol addiction
  • inability to tell about the traumatic events
  • cardiac problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: standard
EMDR treatment with bilateral stimulation via eye movement
EMDR treatment with bilateral stimulation via eye movement
Eye Movement Desensitization and Reprocessing (EMDR)
Experimental: fixed
EMDR treatment with eyes fixed
Eye Movement Desensitization and Reprocessing (EMDR)
EMDR treatment with fixed eyes
Experimental: no focus
trauma exposition without external stimulus
Eye Movement Desensitization and Reprocessing (EMDR)
trauma exposure without external focus

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
CAPS-2: Clinical Administered PTSD Scale
Time Frame: 30 minutes
30 minutes

Secondary Outcome Measures

Outcome Measure
Time Frame
IES - Impact of Events Scale
Time Frame: 10 minutes
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Martin Sack, PHD, Technical University of Munich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2010

Primary Completion (Anticipated)

January 1, 2012

Study Completion (Anticipated)

April 1, 2012

Study Registration Dates

First Submitted

June 17, 2010

First Submitted That Met QC Criteria

September 24, 2010

First Posted (Estimate)

September 27, 2010

Study Record Updates

Last Update Posted (Estimate)

September 27, 2010

Last Update Submitted That Met QC Criteria

September 24, 2010

Last Verified

September 1, 2010

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-Traumatic Stress Disorder

Clinical Trials on standard

3
Subscribe